Bayer targets return to mid-single-digit pharma growth by 2027

Core Viewpoint - Bayer aims to achieve mid-single-digit percentage growth in its pharmaceuticals business by 2027 and increase operating margins to approximately 30% by 2030 [1] Group 1 - Bayer's pharmaceuticals business is targeting a return to growth by no later than 2027 [1] - The company plans to enhance its operating margins to around 30% by the year 2030 [1]